High efficacy of alectinib in a patient with advanced lung adenocarcinoma with 2 rare ALK fusion sites: a case report

High efficacy of alectinib in a patient with advanced lung adenocarcinoma with 2 rare ALK fusion sites: a case report

Saved in:
Bibliographic Details
Main Authors: Li, Yan (Author) , Duan, Peng (Author) , Guan, Yan (Author) , Chen, Qing (Author) , Grenda, Anna (Author) , Christopoulos, Petros (Author) , Denis, Marc G. (Author) , Guo, Qisen (Author)
Format: Article (Journal)
Language:English
Published: January 2022
In: Translational Lung Cancer Research
Year: 2022, Volume: 11, Issue: 1, Pages: 100-110
ISSN:2226-4477
DOI:10.21037/tlcr-21-1039
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.21037/tlcr-21-1039
Verlag, lizenzpflichtig, Volltext: https://tlcr.amegroups.com/article/view/60587
Get full text
Author Notes:Yan Li, Peng Duan, Yan Guan, Qing Chen, Anna Grenda, Petros Christopoulos, Marc G. Denis, Qisen Guo
Description
Summary:High efficacy of alectinib in a patient with advanced lung adenocarcinoma with 2 rare ALK fusion sites: a case report
Item Description:Gesehen am 19.09.2022
Physical Description:Online Resource
ISSN:2226-4477
DOI:10.21037/tlcr-21-1039